Clinical islet transplantation has progressed considerably over the past 12 years, and> 750
patients with type 1 diabetes have received islet transplants internationally over this time …

The liver is the current site of choice for pancreatic islet transplantation, even though it is far
from being an ideal site because of immunologic, anatomic, and physiologic factors leading …

Clinical islet transplantation: is the future finally now? : Current Opinion in Organ
Transplantation Clinical islet transplantation: is the future finally now? : Current Opinion in …

The portal vein is currently the site of choice for clinical islet transplantation, even though it is
far from being an ideal site. Low oxygen tension and the induction of an inflammatory …

GUIDELINE DEVELOPMENT Non-alcoholic steatohepatitis (NASH) is an increasing cause
of liver disease necessitating liver transplantation. In patients with advanced NASH, there …

Background: 3D bioprinting is the future of constructing functional organs. Creating a
bioactive scaffold with pancreatic islets presents many challenges. The aim of this paper is …

Although islet transplantation has demonstrated its potential use in treating type 1 diabetes,
this remains limited by the need for daily immunosuppression. Islet encapsulation was then …

PURPOSE: Diabetes mellitus is a group of debilitating and costly diseases with multiple
serious complications. Lower urinary tract complications or diabetic uropathy are among the …

In the last 15 years, clinical islet transplantation has made the leap from experimental
procedure to standard of care for a highly selective group of patients. Due to a risk/benefit …

Transplantation of mature islets into portal vein has been most effective thus far, although
attrition of transplanted islets constitutes a major limitation, and alternative approaches are …